Advances in Herbal Research

1. Introduction

Diabetes mellitus (DM) has become one of the most persistent and disruptive non-communicable diseases of the modern era. What was once considered a condition largely concentrated in older or more affluent populations has, over time, evolved into a widespread global public health crisis. Today, diabetes affects people across age groups, income levels, and geographic regions, with particularly steep consequences in low- and middle-income countries where healthcare systems are often already under strain (Arokiasamy et al., 2021; Saeedi et al., 2019). Although the disease is clinically defined by chronic hyperglycemia, its real burden extends far beyond elevated blood glucose. Diabetes is, in many respects, a systemic metabolic disorder—one that progressively damages the kidneys, vasculature, nerves, retina, and cardiovascular system, while also imposing long-term emotional, social, and financial stress on patients and their families (Cho et al., 2018; Tareen & Tareen, 2017).

The scale of the problem is difficult to ignore. According to the International Diabetes Federation, approximately 425 million adults were living with diabetes in 2017, and that number is expected to rise substantially in the coming decades (Cho et al., 2018). Updated global projections have continued to reinforce the same concern: diabetes is not merely increasing—it is accelerating, especially in regions undergoing rapid nutritional, demographic, and lifestyle transitions (Saeedi et al., 2019). South Asia, in particular, has emerged as a high-burden zone, where urbanization, reduced physical activity, changing dietary patterns, and persistent health inequities have converged in ways that make diabetes increasingly common and increasingly difficult to control (Arokiasamy et al., 2021).

Bangladesh reflects this reality with particular urgency. Over the past few decades, the country has experienced a marked rise in diabetes prevalence, with estimates varying widely across populations and study settings, but consistently indicating a substantial and growing burden. This increase is occurring alongside rapid social and nutritional change, creating a complex environment in which traditional dietary practices, modern processed food consumption, limited preventive screening, and variable treatment access all intersect (Cho et al., 2018; Rahman et al., 2025; Saeedi et al., 2019). For many individuals in Bangladesh, diabetes is not simply a medical diagnosis—it becomes a lifelong condition that reshapes daily living, food habits, work capacity, and household economics.

Conventional diabetes treatment has, of course, improved considerably over time. Metformin remains a cornerstone of type 2 diabetes management because of its relatively favorable safety profile, affordability, and clinical effectiveness, while newer drug classes have expanded therapeutic possibilities by offering cardiovascular and renal benefits in addition to glycemic control (Schlender et al., 2017; Weinberg Sibony et al., 2023; Zhou et al., 2018). Yet despite these advances, current treatment approaches are not without limitations. In routine practice, many patients struggle with medication adherence, treatment fatigue, side effects, financial barriers, and the gradual progression of disease despite pharmacologic therapy. Some agents may cause hypoglycemia, gastrointestinal discomfort, weight gain, or tolerability issues, while others remain inaccessible to large segments of the population due to cost or availability (Russell‐Jones & Khan, 2007; Weinberg Sibony et al., 2023).

This therapeutic gap—between what is clinically recommended and what is practically sustainable—has helped maintain interest in food-based and plant-derived approaches to diabetes management. In many parts of the world, especially in South Asia, medicinal plants, household spices, traditional vegetables, and functional fruits have long been used not only as dietary staples but also as informal therapeutic agents. In Bangladesh, this overlap between food and medicine is especially important. Bitter melon, fenugreek, neem, jamun, turmeric, and a range of local vegetables and herbs are widely consumed or recommended in both domestic and traditional healing contexts for their perceived ability to “control sugar” or improve metabolic health (Baset et al., 2020; Jalil et al., 2013; Rizvi et al., 2022; Singh et al., 2011).

And to be fair, this interest is not based solely on tradition. A growing body of preclinical and mechanistic research suggests that many plant-derived foods and phytochemicals may influence diabetes-related pathways through several biologically plausible mechanisms. These include enhancement of insulin sensitivity, stimulation of glucose uptake, inhibition of carbohydrate-digesting enzymes, attenuation of oxidative stress, modulation of inflammatory signaling, and support of pancreatic β-cell function (Alam et al., 2022; Shanak et al., 2019; Singh et al., 2022). Such multi-target actions are particularly appealing in diabetes, a disease that is itself multifactorial and metabolically interconnected.

Still, the evidence is uneven. This is where the issue becomes more complicated. While a large number of medicinal plants, fruits, vegetables, and spices used in Bangladesh have been reported to possess antidiabetic potential, the scientific evidence supporting their efficacy remains fragmented. Much of the literature consists of ethnobotanical documentation, in vitro assays, animal experiments, and small exploratory studies. Human clinical evidence is comparatively limited, and even where beneficial findings exist, many studies differ substantially in plant part used, extraction method, dosage, duration, and outcome reporting (Alam et al., 2022; Di Lorenzo et al., 2015). As a result, the literature contains promise—but not always clarity.

This lack of standardization has practical consequences. In community settings, many individuals consume herbal preparations, juices, powders, teas, or concentrated food extracts with the assumption that “natural” necessarily means “safe.” But natural products are not automatically harmless, especially when used in uncontrolled doses, combined with antidiabetic drugs, or consumed for prolonged periods without clinical supervision. Questions of efficacy, safe dosage, herb–drug interaction, organ toxicity, and long-term metabolic impact remain insufficiently resolved for many commonly used agents (Di Lorenzo et al., 2015).

Against this background, the present review was undertaken to critically examine the commonly used antidiabetic medicinal plants, fruits, vegetables, and spices available in Bangladesh, with particular attention to their reported mechanisms of action, metabolic relevance, therapeutic promise, and translational limitations. Rather than treating these food-based agents as either folklore or pharmaceutical equivalents, this review aims to place them in a more balanced scientific context. In doing so, it seeks to clarify what is currently supported by evidence, what remains uncertain, and where future research is most urgently needed. Ultimately, a more rigorous understanding of these locally available bioactive resources may help support safer, more informed, and culturally relevant strategies for diabetes management in Bangladesh and comparable settings.

2. Methods

2.1 Review Design and Search Strategy

This review was conducted as a structured narrative synthesis with systematic search elements to identify and evaluate published evidence on the antidiabetic potential of medicinal plants, fruits, vegetables, and spices commonly used in Bangladesh. The methodological approach was designed to improve transparency, reproducibility, and relevance to both biomedical and ethnopharmacological research contexts.

A literature search was performed across three major databases: PubMed, Scopus, and Google Scholar. PubMed was prioritized for peer-reviewed biomedical literature, while Scopus and Google Scholar were used to broaden retrieval and capture potentially relevant interdisciplinary or ethnobotanical studies. Searches were conducted for studies published between January 2015 and December 2025, with selective inclusion of older landmark studies where they were considered mechanistically or historically important to the interpretation of antidiabetic activity (Cho et al., 2018; Saeedi et al., 2019).

The search strategy combined controlled biomedical concepts and free-text terms. Core search strings included combinations of the following terms: “diabetes mellitus,” “type 2 diabetes,” “antidiabetic plants,” “medicinal plants Bangladesh,” “bioactive compounds,” “phytochemicals,” “glucose homeostasis,” “insulin sensitivity,” “oxidative stress,” “traditional medicine,” “fruit extract,” “vegetable extract,” and “spice extract.” Where appropriate, individual plant names and botanical species reported in Bangladeshi ethnomedicinal use were also searched separately. Reference lists of relevant review articles and primary studies were manually screened to identify additional eligible studies (Alam et al., 2022; Kasole et al., 2019).

2.2 Eligibility Criteria and Study Selection

Studies were considered eligible if they reported experimental, preclinical, clinical, or mechanistic evidence related to the antidiabetic effects of plant-derived foods or botanical agents relevant to Bangladeshi dietary or traditional medicinal use. Included studies had to report at least one measurable metabolic outcome, such as fasting blood glucose, postprandial glucose, HbA1c, insulin sensitivity, glucose uptake, lipid profile, oxidative stress markers, or diabetes-related enzyme inhibition.

Studies were excluded if they were editorials, opinion pieces, conference abstracts without full data, duplicate publications, or articles lacking sufficient methodological detail. Reports were also excluded if they focused on unrelated disease models or described herbal use without any experimental, biochemical, or clinical evidence. Preference was given to studies that provided at least partial information on dosage, extract type, route of administration, and proposed mechanism of action (Di Lorenzo et al., 2015; Weinberg Sibony et al., 2023).

Titles and abstracts were initially screened for relevance, followed by full-text review where eligibility remained plausible. When multiple articles reported overlapping findings on the same compound or plant, the most methodologically informative and biologically relevant evidence was prioritized.

2.3 Data Extraction, Synthesis, and Methodological Considerations

Data were extracted manually into a structured evidence matrix. The following variables were recorded where available: plant species, local/common name, plant part used, extract or preparation type, identified bioactive compounds, study model, dose, duration, route of administration, reported metabolic effects, and proposed antidiabetic mechanism. Particular attention was given to pathways involving insulin signaling, glucose transport, carbohydrate-digesting enzymes, lipid metabolism, oxidative stress, and pancreatic β-cell protection (Shanak et al., 2019; Singh et al., 2022).

Because of substantial heterogeneity in study designs, experimental models, and outcome reporting, a qualitative synthesis was performed rather than a formal meta-analysis. Evidence was interpreted comparatively, with greater weight given to studies demonstrating biological plausibility, reproducible metabolic endpoints, and stronger methodological clarity. This review also acknowledges several limitations, including publication bias, language restriction to English-language literature, uneven extract standardization, and the continued dominance of preclinical rather than human clinical evidence in this field (Alam et al., 2022; Di Lorenzo et al., 2015).

Finally, ethnomedicinal relevance was contextualized using published reports from Bangladesh documenting the traditional use of locally available food plants and medicinal botanicals for glycemic control, especially in rural and low-resource settings where food and medicine often remain deeply interconnected (Kasole et al., 2019).

3. Mechanistic Basis of Plant-Derived Antidiabetic Activity

3.1 Metabolic Pathways Relevant to Glycemic Regulation

A clearer understanding of how plant-derived agents may influence diabetes begins, perhaps unavoidably, with the core metabolic pathways that regulate glucose and lipid homeostasis. As illustrated in (Figure 1), glucose entering the cell through glucose transporters (GLUTs) is first directed into glycolysis, where it is converted into pyruvate. Pyruvate then enters the mitochondria and is further metabolized into acetyl-CoA, a central substrate that links carbohydrate metabolism to the tricarboxylic acid (Krebs) cycle and lipid synthesis. Under physiologic conditions, these pathways remain tightly coordinated. In diabetes, however, this balance is disrupted, leading to impaired glucose uptake, abnormal hepatic glucose production, oxidative stress, and lipid dysregulation (Panov et al., 2024; Rahman et al., 2025; Shanak et al., 2019; Tufael et al., 2023).

This disruption is not limited to glucose metabolism alone. Glycogenolysis, gluconeogenesis, fatty acid β-oxidation, and lipogenesis all contribute to the broader metabolic phenotype of diabetes, especially in insulin-resistant states. Accordingly, antidiabetic food plants and medicinal botanicals may act through several complementary mechanisms rather than a single pathway. These include enhancement of insulin signaling, promotion of GLUT-mediated glucose uptake, suppression of carbohydrate-digesting enzymes, reduction of oxidative stress, preservation of pancreatic β-cell function, and modulation of lipid metabolism. That multi-target nature is, in many ways, what makes plant-derived antidiabetic agents scientifically intriguing.

4. Antidiabetic Medicinal Plants Commonly Used in Bangladesh

4.1 Traditional Medicinal Plants with Experimental Antidiabetic Potential

A number of medicinal plants commonly used in Bangladesh have shown promising antidiabetic activity in preclinical, mechanistic, and in some cases early translational studies (Table 1). While the degree of evidence varies considerably across species, a recurring pattern emerges: many of these plants appear to improve glycemic regulation through a combination of insulin-sensitizing, antioxidant, anti-inflammatory, and β-cell protective effects.

Among the most frequently cited examples is Aloe vera (Ghritkumari), which has been reported to reduce blood glucose and improve lipid parameters, potentially through enhanced GLUT-4 expression and improved peripheral

Figure 1. Key metabolic pathways in glycolysis, glycogenolysis and the Krebs cycle to generate ATP shown in blue, along with the lipogenesis (ω) / β-oxidation of fatty acids. The diagram illustrates glucose transport via the GLUT transporter, phosphorylation to glucose-6-phosphate, and additional metabolism to pyruvate. Pyruvate is metabolized in the mitochondria, resulting in Acetyl-CoA production, Kreb cycle entry and lipogenesis or β-oxidation for ATP generation.

Table 1. Effects of Various Plant Extracts on Diabetes Management in Experimental Models.

Table 2. Effects of Various Plant Extracts on Diabetes Management in Experimental Models.

Table 3. Effects of Various Plant Extracts on Diabetes Management in Experimental Models.

Table 4. Effects of Various Plant Extracts on Diabetes Management in Experimental Models.

Figure 2. Bioactive available from plant-based antidiabetic agents’ bioavailability, absorption and metabolism. The figure shows how these compounds with poor solubility and low bioavailability, are metabolized in the digestive tract. After oral intake, the compounds experience hepatic first-pass metabolism by the liver, generating bioactive metabolites that mediate their therapeutic action. Nanoformulations such as micelles, cyclodextrins, and nanoemulsions are utilized for bioavailability enhancement to increase solubility and therapeutic efficacy with improved absorption in the small intestine (Zivković et al., 2024).

glucose uptake (Deora et al., 2021). Similarly, Azadirachta indica (Neem) has attracted attention for its capacity to modulate insulin-related signaling pathways, including IR, IRS-1, Akt, and GLUT-4, suggesting a mechanistic role in improving insulin sensitivity and metabolic control (Jalil et al., 2013; Satyanarayana et al., 2015).

Other medicinal plants appear to act through broader metabolic restoration. Terminalia chebula (Horitoki) has been associated with reduced hyperglycemia, improved insulin sensitivity, and attenuation of oxidative stress, while Trigonella foenum-graecum (Fenugreek) may support pancreatic function and enhance endogenous insulin activity (Agrawal & Kulkarni, 2023; Baset et al., 2020; Mesallam et al., 2018). Ocimum sanctum (Tulsi) and Swertia chirata (Chirata) have also shown glucose-lowering potential, likely through effects on insulin action and cellular glucose metabolism (Akbar, 2020; Satapathy et al., 2017).

A few plants in this category may also offer systemic metabolic protection beyond glycemia alone. Withania somnifera (Ashwagandha) has been linked to improved insulin sensitivity and reduced inflammatory burden, while Terminalia arjuna (Arjun bark) has shown possible protective effects on the liver, kidneys, and pancreas in experimental settings (Alhasani et al., 2026; Haque et al., 2025). Likewise, psyllium husk, flaxseed, and chia seed-related dietary interventions may contribute to improved fasting glucose, HbA1c, and cardiometabolic risk markers, suggesting that some “medicinal plants” in practice function at the border of nutraceutical and therapeutic food (Gholami et al., 2024; Noreen et al., 2023; Saadh et al., 2025).

5. Antidiabetic Fruits with Potential Functional and Therapeutic Relevance

5.1 Fruit-Derived Agents and Glycemic Modulation

Several fruits and fruit-derived plant parts commonly available in Bangladesh have also demonstrated antidiabetic potential (Table 2). Notably, the biologically active components are not always concentrated in the edible pulp alone; in many cases, leaves, seeds, bark, or peel fractions appear metabolically relevant.

Mangifera indica (Mango), particularly leaf-associated extracts, has been reported to reduce blood glucose and improve metabolic status, possibly through preservation of pancreatic β-cell integrity and better regulation of glycogen and lipid metabolism (Perpétuo & Salgado, 2003). Syzygium cumini (Jamun), one of the most culturally recognized antidiabetic fruits in South Asia, continues to be supported by experimental evidence indicating antihyperglycemic and antioxidant activity (Arun et al., 2011; Rizvi et al., 2022).

Similarly, Psidium guajava (Guava leaf), Emblica officinalis (Amla), Aegle marmelos (Bel), and Punica granatum (Pomegranate) have shown effects on glucose regulation, insulin signaling, oxidative balance, and in some studies pancreatic tissue protection (Gandhi et al., 2012; Liu et al., 2015; Majeed et al., 2023; Zhang et al., 2022). Phoenix dactylifera (Date fruit) and Juglans regia (Walnut leaf) have also been associated with improvements in metabolic and organ-level outcomes, though the quality and translational maturity of the evidence still vary (Mahomoodally et al., 2024; Mirzababaei et al., 2022).

Taken together, these fruit-based agents appear to influence diabetes through several overlapping mechanisms—particularly antioxidant defense, insulin pathway support, and enzyme modulation—rather than by acting as simple glucose-lowering substitutes.

6. Antidiabetic Vegetables and Food-Based Glycemic Modifiers

6.1 Common Vegetables with Reported Metabolic Benefits

Vegetables used in the Bangladeshi diet may represent one of the most practical and culturally accessible categories of antidiabetic food agents (Table 3). Their importance lies not only in therapeutic potential but also in feasibility of integration into routine dietary habits.

Among the vegetables reported to show antidiabetic effects are Lagenaria siceraria (Lau), Raphanus sativus (Mula), Brassica oleracea (Broccoli), Ipomoea aquatica (Water spinach), Luffa acutangula (Ridge gourd), and Cucurbita maxima (Pumpkin). These foods have been associated with improved glycemic control through mechanisms such as α-amylase and α-glucosidase inhibition, enhanced insulin action, antioxidant activity, reduced inflammation, and possible β-cell support (Bano et al., 2025; Das et al., 2024; Kaur et al., 2025; Nakakaawa et al., 2025; Sultana et al., 2020).

Some findings are especially interesting because they blur the line between diet and pharmacology. For example, Colocasia esculenta (Cocoyam) and Musa paradisiaca (Unripe plantain/green banana) have shown effects on glucose and lipid metabolism in diabetic models, suggesting that glycemic modulation may arise not only from isolated phytochemicals but also from the broader nutritional matrix of these foods (Eleazu et al., 2016; Oyeyinka & Afolayan, 2020). That distinction matters. It suggests that the antidiabetic value of these vegetables may be partly biochemical and partly dietary-structural.

7. Antidiabetic Spices as Metabolic Modulators

7.1 Culinary Spices with Mechanistic Relevance in Diabetes

Spices occupy a unique position in traditional medicine because they are consumed regularly, often in small doses, yet may exert biologically meaningful effects over time. In the context of diabetes, several spices used in Bangladesh have shown potential roles in glucose regulation, insulin sensitivity, lipid balance, and inflammatory control.

Coriandrum sativum (Coriander), Bunium persicum (Black caraway), Piper nigrum (Black pepper), Piper longum, Zingiber officinale (Ginger), Allium sativum (Garlic), Allium cepa (Onion), Capsicum annuum (Red pepper), and Curcuma longa (Turmeric) have all been reported to influence diabetes-related metabolic endpoints. Proposed mechanisms include enhancement of insulin action, suppression of carbohydrate-digesting enzymes, antioxidant defense, anti-inflammatory signaling, and synergy with standard antidiabetic drugs such as metformin (Aslam et al., 2025; Atal et al., 2016; Huang et al., 2019; Jafari-Maskouni et al., 2020; Kim et al., 2010; Kim et al., 2020; Mahmoud et al., 2022; Nabi et al., 2013; Rahimi-Madiseh et al., 2017).

Among these, black pepper is especially notable because piperine may enhance bioavailability of co-administered compounds, raising the possibility that certain spices do not merely act independently, but may also modify the effectiveness of other plant-derived or conventional therapies.

8. Bioactive Compounds, Bioavailability, and Translational Challenges

8.1 Why Promising Plant Compounds Do Not Always Translate Clinically

Although many plant-derived antidiabetic agents appear mechanistically promising, their therapeutic translation is often constrained by pharmacokinetic limitations (Figure 2). A recurring issue is that numerous bioactive compounds—including polyphenols, flavonoids, alkaloids, and related phytochemicals—have poor oral bioavailability, limited solubility, gastrointestinal instability, or extensive first-pass metabolism (Zivković et al., 2024).

Mangiferin is a useful example. Despite substantial mechanistic interest, its metabolic activity depends not only on ingestion but also on biotransformation into active metabolites such as norathyriol, which may influence the eventual biological response. Similar challenges apply to many hydrophilic or poorly absorbed phytochemicals that show strong in vitro effects but less consistent in vivo performance.

To address this, newer delivery strategies—such as nanoemulsions, micelles, and cyclodextrin-based systems—have been explored to improve compound stability, solubility, intestinal absorption, and systemic availability (Jafari-Maskouni et al., 2020; Rahimi-Madiseh et al., 2017). These formulation approaches may ultimately prove important if plant-derived compounds are to move from promising laboratory findings toward clinically useful metabolic adjuncts.

9. Discussion

9.1 Plant-Derived Antidiabetic Agents as Multi-Target Metabolic Modulators

The rising global burden of diabetes—particularly type 2 diabetes mellitus (T2DM)—has intensified the search for therapeutic strategies that are not only effective, but also affordable, culturally acceptable, and sustainable over time. This is especially relevant in low- and middle-income settings, where the long-term management of diabetes often extends beyond clinical prescriptions and into the realm of diet, traditional medicine, and household-level health practices (Arokiasamy et al., 2021; Campbell, 2001). Within that broader context, the findings summarized in this review suggest that medicinal plants, fruits, vegetables, and spices commonly used in Bangladesh may offer biologically meaningful support for glycemic regulation through multiple complementary mechanisms rather than a single drug-like action.

That point is worth emphasizing. Diabetes is not a one-pathway disease. It involves disrupted insulin signaling, impaired glucose uptake, oxidative stress, chronic low-grade inflammation, altered hepatic metabolism, β-cell dysfunction, dyslipidemia, and, often, progressive cardiovascular and renal risk. It is therefore unsurprising that plant-derived agents showing the most promise are those capable of acting across several of these interconnected metabolic disturbances at once. As outlined in (Figure 1) and supported by the evidence summarized across (Table 1), (Table 2), and (Table 3), many of the reviewed food plants and medicinal botanicals appear to influence pathways related to insulin sensitivity, GLUT-mediated glucose transport, pancreatic preservation, digestive enzyme inhibition, oxidative stress reduction, and lipid homeostasis.

9.2 Mechanistic Relevance of Bioactive Phytochemicals

A central theme emerging from the literature is the importance of bioactive phytochemicals as probable mediators of these effects. Flavonoids, polyphenols, alkaloids, terpenoids, saponins, and related secondary metabolites have repeatedly been implicated in antidiabetic activity, both directly and indirectly (Al-Khayri et al., 2022; Singh et al., 2022). Their importance lies not merely in glucose lowering, but in their ability to intervene at mechanistically meaningful points in metabolic dysfunction.

For example, flavonoids such as quercetin- and kaempferol-like compounds have been associated with antioxidant and anti-inflammatory effects that may attenuate reactive oxygen species (ROS)-driven insulin resistance. Similarly, saponin- and alkaloid-rich plant extracts may enhance insulin secretion, improve cellular glucose transport, or reduce postprandial glycemic excursions through digestive enzyme inhibition (Mirzababaei et al., 2022; Singh et al., 2011). These are not trivial observations. They suggest that many of these agents do not simply “lower sugar” in a vague sense; rather, they may modulate the biochemical environment in which dysglycemia develops and persists.

Compounds such as mangiferin, curcumin, and related polyphenols are especially noteworthy in this regard. These molecules have been linked to improved insulin signaling through pathways involving AMPK activation, insulin receptor modulation, improved glucose transporter activity, and attenuation of inflammatory and oxidative burden (Huang et al., 2019; Perpétuo & Salgado, 2003; Zivković et al., 2024). This helps explain why certain fruits and spices—such as mango-associated extracts and turmeric—continue to attract scientific interest even when the clinical evidence remains incomplete.

9.3 Beyond Glucose: Why Lipid Metabolism and Cardiometabolic Risk Also Matter

One of the more valuable aspects of the reviewed evidence is that many of these plant-derived agents appear to influence lipid metabolism as well as glucose control. That matters because T2DM rarely exists in isolation. It is often accompanied by hypertriglyceridemia, low HDL cholesterol, central adiposity, fatty liver, endothelial dysfunction, and a substantially elevated risk of cardiovascular disease.

Several reviewed agents—including flaxseed, chia seed, and other omega-3-rich or fiber-rich foods—have shown potential to improve lipid profiles, reduce inflammatory burden, and support broader cardiometabolic health (Al-Madhagy et al., 2023; Noreen et al., 2023; Saadh et al., 2025). In this sense, the value of plant-derived antidiabetic agents may extend beyond glycemic indices alone. Their greatest utility may, in some cases, lie in their ability to improve the overall metabolic terrain in which diabetes progresses.

This broader view is especially important for dietary or culturally embedded interventions. A vegetable, fruit, or spice used regularly within a population may not need to act as strongly as a pharmaceutical drug to still have meaningful public health relevance—particularly if it contributes modest but cumulative improvements across glycemia, lipid balance, oxidative stress, and inflammatory tone.

9.4 The Major Translational Problem: Bioavailability and Pharmacokinetic Limitations

And yet, despite all of this promise, the gap between mechanistic plausibility and clinical applicability remains substantial. That gap is, in many cases, pharmacokinetic.

As summarized in (Figure 2), many plant-derived bioactive compounds have poor oral bioavailability, limited water solubility, unstable gastrointestinal behavior, or extensive hepatic first-pass metabolism. In practical terms, this means that a compound may appear highly active in vitro, or even in tightly controlled animal models, while still failing to achieve therapeutically meaningful concentrations in human tissues after routine oral consumption (Jafari-Maskouni et al., 2020; Rahimi-Madiseh et al., 2017; Zivković et al., 2024).

This is particularly relevant for compounds such as curcumin, mangiferin, and several flavonoids, which often suffer from poor absorption despite strong mechanistic appeal. Lipophilicity, molecular instability, enzymatic transformation, and intestinal permeability all contribute to this challenge. So while the biological rationale for these compounds is often compelling, their real-world efficacy depends not only on what they do in principle, but on whether they can actually reach the tissues where they are needed in meaningful concentrations.

9.5 Emerging Solutions: Nanoformulation and Delivery Optimization

One of the more encouraging developments in this field is the increasing use of delivery-enhancing technologies to overcome these pharmacokinetic barriers. Nanoemulsions, micelles, cyclodextrin complexes, and related formulation systems have shown potential to improve solubility, stability, intestinal uptake, and systemic delivery of poorly absorbed phytochemicals (Ezeani et al., 2017; Jafari-Maskouni et al., 2020; Sena-Júnior et al., 2025).

These approaches are important because they shift the conversation from “Does this compound work in theory?” to “Can this compound be delivered effectively enough to matter clinically?” That is a much more translationally useful question. In some cases, these delivery systems may also help preserve compound integrity during digestion, reduce degradation, and improve therapeutic consistency—issues that are often overlooked in purely descriptive ethnobotanical or nutritional discussions.

Still, formulation innovation should not be mistaken for clinical validation. Improved delivery may strengthen biological plausibility, but it does not replace the need for human efficacy and safety trials.

9.6 Why the Current Evidence Base Remains Insufficient for Clinical Recommendation

Perhaps the most important limitation of the field, and certainly of the evidence synthesized in this review, is that human clinical evidence remains comparatively sparse. A large proportion of the available literature still derives from in vitro experiments, animal models, mechanistic assays, or small preclinical investigations. These studies are scientifically useful and often hypothesis-generating, but they are not enough—on their own—to justify confident therapeutic recommendations for routine human use (Kim et al., 2010; Rahmatullah et al., 2012).

There are also issues of standardization that continue to weaken reproducibility across studies. Plant species may vary by region, cultivar, growing condition, harvest timing, extraction method, and active constituent concentration. In many studies, the exact phytochemical composition of the tested extract is not fully characterized. That makes comparison difficult and replication even harder. Two studies may appear to test the “same plant” while in fact evaluating chemically distinct preparations.

Equally important, the assumption that plant-based therapies are inherently safe should be approached with caution. While many natural agents may indeed have favorable tolerability profiles, “natural” does not automatically mean harmless—particularly when used chronically, in concentrated forms, or in combination with standard antidiabetic drugs. The possibility of herb–drug interactions, cumulative toxicity, or unintended metabolic effects remains underexplored for many commonly used preparations.

9.7 Future Directions: Toward Evidence-Based Integration Rather Than Informal Use

Looking ahead, the most promising path may not be the replacement of conventional antidiabetic drugs, but rather the evidence-based integration of selected plant-derived agents into broader diabetes management strategies. This could include use as dietary adjuncts, preventive metabolic supports, or combination therapies that complement—not substitute—established pharmacologic care.

Some preliminary evidence already hints at this possibility. For example, piperine-containing black pepper has shown the capacity to enhance the effectiveness or bioavailability of co-administered agents such as metformin, raising the prospect of rational combination strategies rather than isolated botanical use (Atal et al., 2016). If developed carefully, such combinations could offer practical value in settings where affordability, adherence, and cultural familiarity matter greatly.

However, progress in this field will require a shift from broad claims to more disciplined evidence generation. Future research should prioritize:

• standardized extract characterization,
• dose-response evaluation,
• pharmacokinetic profiling,
• herb–drug interaction assessment,
• and, most importantly, well-designed human clinical trials.

Without that, the field risks remaining permanently “promising” but never fully translatable.

9.8 Overall Interpretation

Taken together, the findings of this review support a cautious but meaningful conclusion: plant-derived foods and medicinal botanicals commonly used in Bangladesh do appear to possess substantial antidiabetic potential, but that potential is currently supported more strongly by mechanistic and preclinical evidence than by definitive clinical proof. Their value likely lies not in acting as simple natural alternatives to drugs, but in offering multi-target metabolic support that may be especially relevant in dietary, preventive, and adjunctive therapeutic contexts.

That, perhaps, is the most balanced interpretation. The science is promising. The tradition is rich. But between traditional use and clinical recommendation, there remains a necessary space for rigor.

10. Conclusion

This review highlights a growing and increasingly important body of evidence suggesting that medicinal plants, fruits, vegetables, and spices commonly used in Bangladesh may offer meaningful support in diabetes management. Collectively, these plant-derived agents appear to act through a wide range of biologically relevant mechanisms, including enhancement of insulin sensitivity, improvement of glucose uptake, inhibition of carbohydrate-digesting enzymes, attenuation of oxidative stress, protection of pancreatic β-cells, and modulation of lipid metabolism. In that sense, their therapeutic relevance lies not in a single pharmacological action, but rather in their ability to influence the broader metabolic disturbances that characterize diabetes.

At the same time, the current evidence should be interpreted with caution. Much of the available literature remains rooted in in vitro experiments, animal studies, and mechanistic investigations, while robust human clinical trials remain comparatively limited. Questions surrounding dose standardization, extract composition, long-term safety, herb–drug interaction, and reproducibility still need much clearer answers before these agents can be confidently incorporated into routine evidence-based diabetes care.

Even so, the importance of these findings should not be underestimated. In Bangladesh and similar settings, where food, tradition, and medicine often remain deeply interconnected, locally available plant-based resources may offer practical and culturally acceptable opportunities for adjunctive metabolic support. Their value may be especially relevant in prevention-oriented nutrition, supportive dietary strategies, and future combination approaches alongside conventional therapy.

Ultimately, plant-derived antidiabetic agents should not be viewed simply as “natural alternatives,” but as scientifically promising metabolic modulators that deserve more rigorous translational attention. With better standardization, stronger clinical validation, and improved delivery strategies, these commonly used botanical and food-based resources may yet contribute meaningfully to safer, more accessible, and more context-relevant diabetes management.

References